Eos SENOLYTIX, Inc.ES
SEC Form D filing

Eos SENOLYTIX, Inc.

Biotech · Series B · Regulation D 506(b) · TX · Filed June 12, 2026

Offering amount
$25.0M
Exemption
Reg D 506(b)
Issuer state
TX
Filing date
June 12, 2026
Signature date
June 12, 2026
CIK
0002129803

Summary

Auto-generated

biotech company developing senolytic therapies, $25M Series B in TX

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.